307 related articles for article (PubMed ID: 11293909)
1. Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations.
Wu SL; Li W; Wells A; Dasgupta A
Am J Clin Pathol; 2001 Apr; 115(4):600-4. PubMed ID: 11293909
[TBL] [Abstract][Full Text] [Related]
2. Digitoxinlike and digoxinlike immunoreactivitis in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities.
Luke M; Dasgupta A
Ther Drug Monit; 1997 Apr; 19(2):230-5. PubMed ID: 9108656
[TBL] [Abstract][Full Text] [Related]
3. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
Dasgupta A; Trejo O
Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
[TBL] [Abstract][Full Text] [Related]
4. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
Lackner TE; Lau BW; Parvin C; Valdes R
Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
[TBL] [Abstract][Full Text] [Related]
5. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
Dasgupta A
Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
[TBL] [Abstract][Full Text] [Related]
6. Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay.
Crossey MJ; Dasgupta A
Ther Drug Monit; 1997 Apr; 19(2):185-90. PubMed ID: 9108648
[TBL] [Abstract][Full Text] [Related]
7. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
Li J; Wu Z; Xu J; Zhou Y; Chu X
Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
[TBL] [Abstract][Full Text] [Related]
8. False-positive serum digoxin concentrations determined by three digoxin assays in patients with liver disease.
Frisolone J; Sylvia LM; Gelwan J; Pal S; Pellechia C
Clin Pharm; 1988 Jun; 7(6):444-9. PubMed ID: 3402179
[TBL] [Abstract][Full Text] [Related]
9. Endogenous glycosides in critically ill patients.
Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
[TBL] [Abstract][Full Text] [Related]
10. Comparison of microparticle enzyme and fluorescence polarization immunoassays in pediatric patients not receiving digoxin.
Chicella M; Branim B; Lee KR; Phelps SJ
Ther Drug Monit; 1998 Jun; 20(3):347-51. PubMed ID: 9631935
[TBL] [Abstract][Full Text] [Related]
11. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
Li JH; Wu ZG; Xu JQ; Zhou Y
Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
[TBL] [Abstract][Full Text] [Related]
12. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
13. Unexpected suppression of total digoxin concentrations by cross-reactants in the microparticle enzyme immunoassay: elimination of interference by monitoring free digoxin concentration.
Dasgupta A; Scott J
Am J Clin Pathol; 1998 Jul; 110(1):78-82. PubMed ID: 9661925
[TBL] [Abstract][Full Text] [Related]
14. Digoxin-like immunoreactive substance in chronic hemodialysis patients: effect on digitoxin radioimmunoassay.
Walker JA; Bialy GB; Walker VC; Sherman RA; Eisinger RP
Am J Nephrol; 1987; 7(4):300-2. PubMed ID: 3688041
[TBL] [Abstract][Full Text] [Related]
15. Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind).
Dasgupta A; Reyes MA
Am J Clin Pathol; 2005 Aug; 124(2):229-36. PubMed ID: 16040294
[TBL] [Abstract][Full Text] [Related]
16. Increased digitalis-like immunoreactive substances in neonatal plasma measured using fluorescence polarization immunoassay.
Ijiri Y; Hayahi T; Ogihara T; Ohi K; Suzuki K; Tamai H; Kitaura Y; Takenaka H; Tanaka K
J Clin Pharm Ther; 2004 Dec; 29(6):565-71. PubMed ID: 15584945
[TBL] [Abstract][Full Text] [Related]
17. Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay.
Datta P; Dasgupta A
Ther Drug Monit; 1998 Dec; 20(6):663-8. PubMed ID: 9853984
[TBL] [Abstract][Full Text] [Related]
18. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
Mojaverian P; Green PJ; Jhangiania RK; Chase GD
J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
[TBL] [Abstract][Full Text] [Related]
19. Digoxin-like immunoreactive substance in postmortem blood of infants and children.
Spiehler VR; Fischer WR; Richards RG
J Forensic Sci; 1985 Jan; 30(1):86-91. PubMed ID: 3981124
[TBL] [Abstract][Full Text] [Related]
20. Endogenous digoxin-like substance in liver failure.
Lucena MI; Andrade RJ; Fraile JM; Alcantara R; Gonzalez-Correa JA; De La Cuesta FS
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):567-9. PubMed ID: 7834165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
